Advertisement Elsevier to provide Reaxys access to Pharmaron - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Elsevier to provide Reaxys access to Pharmaron

Elsevier, a provider of medical information products and services, has entered into a multi-year contract under which it will provide unlimited Reaxys access to all Pharmaron researchers.

Reaxys is a web-based chemistry workflow solution which supports research and fuels discovery by integrating searches for reaction and substance data with synthesis planning and chemical sourcing.

The solution aids Pharmaron to continue to consolidate its scientific excellence and to stay competitive in drug R&D, and also ensure that Pharmaron has resources available to provide research and solutions to their customers.

Pharmaron Chemistry senior vice president Tongqian Chen said Reaxys provides information which allows their scientists in the labs to plan and execute in a more productive manner.

Elsevier Pharma and Biotech Group MD Mark van Mierle said they are committed to ensure that researchers can take their findings from Reaxys and apply them effectively in the lab.